Dupont Capital Management Corp acquired a new position in shares of The Clorox Company (NYSE:CLX – Get Rating) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 837 shares of the company’s stock, valued at approximately $107,000.
Other institutional investors also recently bought and sold shares of the company. Federated Hermes Inc. lifted its position in shares of Clorox by 86.2% during the second quarter. Federated Hermes Inc. now owns 1,945,898 shares of the company’s stock worth $274,332,000 after purchasing an additional 901,040 shares in the last quarter. State Street Corp lifted its position in shares of Clorox by 9.6% during the second quarter. State Street Corp now owns 8,907,083 shares of the company’s stock worth $1,255,721,000 after purchasing an additional 778,269 shares in the last quarter. Invesco Ltd. lifted its position in shares of Clorox by 38.2% during the first quarter. Invesco Ltd. now owns 1,051,679 shares of the company’s stock worth $146,216,000 after purchasing an additional 290,833 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Clorox by 130.6% in the second quarter. Allspring Global Investments Holdings LLC now owns 449,287 shares of the company’s stock valued at $63,340,000 after acquiring an additional 254,476 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Clorox by 51.3% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 715,663 shares of the company’s stock valued at $100,894,000 after acquiring an additional 242,651 shares during the last quarter. 79.12% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on CLX shares. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Clorox from $148.00 to $151.00 and gave the stock a “hold” rating in a research report on Tuesday, December 6th. DA Davidson increased their target price on Clorox from $124.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, November 2nd. UBS Group increased their target price on Clorox from $119.00 to $129.00 and gave the stock a “sell” rating in a report on Wednesday, November 2nd. JPMorgan Chase & Co. increased their target price on Clorox from $126.00 to $135.00 and gave the stock an “underweight” rating in a report on Friday, January 13th. Finally, Morgan Stanley increased their target price on Clorox from $130.00 to $142.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 2nd. Nine analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox has a consensus rating of “Reduce” and an average target price of $136.92.
Clorox Stock Performance
Clorox (NYSE:CLX – Get Rating) last issued its quarterly earnings data on Tuesday, November 1st. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.20. Clorox had a return on equity of 83.00% and a net margin of 5.75%. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.69 billion. On average, equities research analysts anticipate that The Clorox Company will post 4.11 EPS for the current year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 10th. Investors of record on Wednesday, January 25th will be issued a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date of this dividend is Tuesday, January 24th. Clorox’s dividend payout ratio (DPR) is 144.79%.
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.